CAR T-cell therapy for cancer leads to similar safety and cancer outcomes in patients with and without preexisting autoimmune ...

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based ...

Astellas has invested heavily in novel technologies that are not necessarily the most successful or popular in the industry.

As you’ll recall, Google has stepped up the pace for Android version releases, so Android 16 is already in development. The aim is to bring the new software to devices earlier in 2025 than usual, with ...